The Genetics Versus Environment in Scleroderma Outcome Study (GENISOS) study showed that CRP can predict mortality in SSc patients, resulting in an early identification of SSc-ILD patients who are more likely to experience worse clinical outcomes [91]. Here, CRP is linked to systemic sclerosis.